Table 3 Linear regression analysis of summed functional assessments (independent variables) in all participants intermediate AMD (n = 168) against VILL subscales (independent variables), controlled for age and sex.

From: Patient-reported vision impairment in low luminance relates to visual function in age-related macular degeneration: A MACUSTAR study report

 

VILL-Reading

VILL-Mobility

VILL-Emotional

β [95% CI]

p-value

β [95% CI]

p-value

β [95% CI]

p-value

Better eye

BCVA, logMAR

−0.27 [−2.87; 2.32]

0.8350

−1.68 [−4.71; 1.35]

0.2744

−5.04 [−10.33; 0.25]

0.0616

LLVA, logMAR

0.55 [−1.16; 2.26]

0.5285

0.20 [−1.80; 2.20]

0.8433

−1.74 [−5.26; 1.77]

0.3292

MA, logMAR

0.27 [−1.61; 2.15]

0.7800

−0.28 [−2.48; −1.92]

0.8027

−3.35 [−7.19; 0.49]

0.0867

PR-CS, logCS

1.16 [−0.34; 2.67]

0.1277

1.79 [0.04; 3.54]

0.0454

1.41 [−1.70; 4.52]

0.3718

Worse eye

BCVA, logMAR

−1.35 [−2.71; 0.02]

0.0531

−1.82 [−3.41; −0.23]

0.0252

−2.40 [−5.22; 0.42]

0.0943

LLVA, logMAR

−1.23 [−2.50; 0.03]

0.0565

−1.62 [−3.10; −0.14]

0.0317

−2.13 [−4.75; 0.49]

0.1103

MA, logMAR

−1.33 [−2.71; 0.04]

0.0576

−1.81 [−3.41; −0.20]

0.0274

−3.36 [−6.17; −0.54]

0.0198

PR-CS, logCS

1.37 [0.07; 2.67]

0.0395

2.17 [0.66; 3.67]

0.0050

1.98 [−0.72; 4.67]

0.1495

  1. BCVA = best-corrected visual acuity; LLVA, low-luminance visual acuity; MA, Moorfields acuity; PR-CS, Pelli-Robson contrast sensitivity; VILL, Vision Impairment in Low Luminance questionnaire. Rows marked bold were statistically significant.